Phenotypic platform better predicts cancer drug effectiveness from the lab to actual tumors. Platform reduces time and money spent on drugs that will not work or will be toxic. Platform removes researcher bias in choosing systems to target for drug discovery. SAN FRANCISCO — Researchers have created...
Sun, Nov 13 2011
Filed under: Filed under: Press Releases, Research, Treatment, Conference, Cancer, Media Materials, AACR, American Association for Cancer Research, meeting, Drug discovery, National Cancer Institute, NCI, angiogenesis, Molecular Targets, AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, Cancer Therapeutics, EORTC, European Organisation for Research and Treatment of Cancer, antiangiogenesis, phenotypic platform, Dr. Enrique Zudaire, cancer drug